Immunovant Inc - Ind Cleared for Imvt-1402 Pivotal Trial in GD Expected by Year-End
Immunovant公司 - 已獲批用於Imvt-1402重要試驗,預計將於年底前完成。
Immunovant Inc - Ind Cleared for Imvt-1402 Pivotal Trial in GD Expected by Year-End
Immunovant公司 - 已獲批用於Imvt-1402重要試驗,預計將於年底前完成。
譯文內容由第三人軟體翻譯。